Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
5 of 5 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Omega-3 and TUDCA have evidence — compare verdict strength side-by-side.
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
250-500mg daily for general support; up to 1500mg for therapeutic use
With meals containing fat, Before or with fatty meals
TUDCA capsules (pure tauroursodeoxycholic acid)
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
4-8 weeks
1-2 weeks
8-12 weeks
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
The bile acid TUDCA and neurodegenerative disorders: An overview
Life sciences (2021) · Systematic review
The tauroursodeoxycholic acid (TUDCA), one of the acids found in bear bile, is a hydrophilic bile acid and naturally produced in the liver by conjugation of taurine to ursodeoxycholic acid (UDCA).
Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure
International journal of molecular sciences (2021) · Systematic review
The potential advantages of whole-food plant-based diets, moderation in salt intake, avoidance of phosphate additives, and regular exercise training and sauna sessions are also discussed.
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
The New England Journal of Medicine (2020) · Rct · n=137
A total of 137 participants were randomly assigned in a 2:1 ratio to receive sodium phenylbutyrate-taurursodiol (89 participants) or placebo (48 participants).
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
Based on one phase 3 RCT in ALS showing modest functional improvement and systematic reviews suggesting neuroprotective effects. Effect size is conservative given single disease population study and limited human data for other neurological conditions.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 6/10) and wins in 2 of 3 categories.
For reduce inflammation, TUDCA has a higher relevance score (95 vs 90).
No known interactions between Omega-3 and TUDCA have been documented in our database. However, always consult a healthcare provider before combining supplements.